Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard

On September 25, 2026, the company received a Nasdaq Hearings Panel notice granting continued listing subject to meeting the $1.00 minimum bid price by September 28, 2026 and the $2.5 million stockholders' equity requirement by January 4, 2027, including a $1.00 closing bid for at least 20 consecut…